Skip to main content

Advertisement

SpringerLink
Log in

Autoimmune subepidermal bullous skin diseases: the impact of recent findings for the dermatopathologist

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

In recent years improved knowledge of the mechanisms of intercellular and cell-matrix adhesion has led to better understanding of the blistering process in many bullous dermatoses. The wide characterisation of adhesion molecules has partially changed some traditional views and invariably has made the routine work of the pathologist more complex. If understanding cell–cell cohesion structures such as desmosomes and adherens junctions is complex enough, the cell-matrix adhesion structures, such as hemidesmosomes and their structural analogues on the basement membrane and superficial dermis, are even more complex. Defects of such structures cause the subepidermal bullous diseases in which there has been most characterisation of the adhesion molecules and has also led to the discovery of new diseases (e.g. p200 pemphigoid). Most of the antigens are also the targets for mutations seen in patients with the inherited type of epidermolysis bullosa, a group of rare blistering genodermatoses. Another important aspect of bullous skin conditions is the more accurate definition of the role of the different inflammatory cells involved in triggering, development and maintenance of these diseases. Recent studies have outlined the important role of T-cell lymphocytes and their cytokines in their pathogenesis. All these studies, based mainly on highly sophisticated ultrastructural and molecular biology techniques, have updated our knowledge of the pathogenesis of blistering diseases. Nevertheless, the diagnostic characterisation of bullous diseases remains sometimes difficult, and some pathological features and mechanisms still represent an enigma. Diseases such as bullous pemphigoid and cicatricial pemphigoid, or anti-laminin cicatricial pemphigoid and acquired bullous epidermolysis share the same molecular target but have very different clinical manifestations. Explaining this phenomenon, probably linked to different expressions of MHC, is one of the challenges for the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.
Fig. 7.
Fig. 8.
Fig. 9.
Fig. 10.
Fig. 11.
Fig. 12.

Similar content being viewed by others

References

  1. Amerio P, Verdolini R, Giangiacomi M, Proietto G, Feliciani C, Offidani A, Bossi G (2000) Expression of eotaxin, interleukin 13 and tumour necrosis factor-alpha in dermatitis herpetiformis. Br J Dermatol 143:974–978

    Article  CAS  PubMed  Google Scholar 

  2. Borrego L, Maynard B, Peterson EA, George T, Iglesias L, Peters MS, Newman W, Gleich GJ, Leiferman KM (1996) Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins. Am J Pathol 148:897–909

    CAS  PubMed  Google Scholar 

  3. Chan LS (1997) Human skin basement membrane in health and in autoimmune diseases Front Biosci 15;2:d343–352

    Google Scholar 

  4. Chan LS, Cooper KD (1994) A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component. Arch Dermatol 130:343–347

    Article  CAS  PubMed  Google Scholar 

  5. Chan LS, Woodley DT(1996) The 105-kDa basement membrane autoantigen p105 is N-terminally homologous to a tumor-associated antigen. J Invest Dermatol 107:209–214

    CAS  PubMed  Google Scholar 

  6. Czech W, Schaller J, Schopf E, Kapp A (1993) Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris. J Am Acad Dermatol 29:210–215

    CAS  PubMed  Google Scholar 

  7. D'Auria L, Cordiali Fei P, Ameglio F (1999) Cytokines and bullous pemphigoid. Eur Cytokine Netw 10:123–134

    CAS  PubMed  Google Scholar 

  8. Engineer L, Bhol K, Ahmed AR (2000) Pemphigoid gestationis: a review. Am J Obstet Gynecol 183:483–491

    Article  CAS  PubMed  Google Scholar 

  9. Engineer L, Bhol K, Kumari S, Razzaque Ahmed A (2001) Bullous pemphigoid: interaction of interleukine 5, anti-basement membrane zone antibodies and eosinophil. A preliminary observation. Cytokine 13:32–38

    CAS  PubMed  Google Scholar 

  10. Fine JD, Eady RA, Bauer EA, Briggaman RA, Bruckner-Tuderman L, Christiano A, Heagerty A, Hintner H, Jonkman MF, McGrath J, McGuire J, Moshell A, Shimizu H, Tadini G, Uitto J (2000) Revised classification system for inherited epidermolysis bullosa: report of the second international consensus meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol 42:1051–1066

    Article  CAS  PubMed  Google Scholar 

  11. Fleming TE, Korman NJ (2000) Cicatricial pemphigoid. J Am Acad Dermatol 43:571–594

    Google Scholar 

  12. Fujimoto W, Ohtsu T, Toi Y, Nakanishi G, Arata J (2000) Linear IgA disease with IgA antibodies directed against 200- and 280-kDa epidermal antigens. Br J Dermatol 142:1213–1218

    Article  CAS  PubMed  Google Scholar 

  13. Fujiwara S, Shinkai H, Takayasu S, Owaribe K, Tsukita S, Kageshita T (1992) A case of subepidermal blister disease associated with autoantibody against 450 kD protein. J Dermatol 19:610–613

    CAS  PubMed  Google Scholar 

  14. Fujiwara S, Kohno K, Iwamatsu A, Shinkai H (1994) A new bullous pemphigoid antigen. Dermatology 189[Suppl 1]:120–122

  15. Gammon WR, Fine JD, Forbes M, Briggaman RA (1992) Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies. J Am Acad Dermatol 27:79–87

    CAS  PubMed  Google Scholar 

  16. Ghohestani RF, Hudson BG, Claudy A, Uitto J (2000) The alpha 5 chain of type IV collagen is the target of IgG autoantibodies in a novel autoimmune disease with subepidermal blisters and renal insufficiency. J Biol Chem 275:16002–16006

    Article  CAS  PubMed  Google Scholar 

  17. Hashimoto T, Amagai M, Watanabe K, Chorzelski TP, Bhogal BS, Black MM, Stevens HP, Boorsma DM, Korman NJ, Gamou S, et al (1995) Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 104:829–834

    Google Scholar 

  18. Hertl M, Riechers R (1999) Analysis of the T cells that are potentially involved in autoantibody production in pemphigus vulgaris. J Dermatol 26:748–752

    CAS  PubMed  Google Scholar 

  19. Kawahara Y, Zillikens D, Yancey KB, Marinkovich MP, Nie Z, Hashimoto T, Nishikawa T (2000) Subepidermal blistering disease with autoantibodies against a novel dermal 200-kDa antigen. J Dermatol Sci 23:93–102

    Article  CAS  PubMed  Google Scholar 

  20. Leivo T, Lohi J, Kariniemi AL, Molander G, Kiraly CL, Kotovirta ML, Owaribe K, Burgeson RE, Leivo I (1999) Hemidesmosomal molecular changes in dermatitis herpetiformis; decreased expression of BP230 and plectin/HD1 in uninvolved skin. Histochem J 31:109–116

    Article  CAS  PubMed  Google Scholar 

  21. Lin MS, Fu CL, Giudice GJ, Olague-Marchan M, Lazaro AM, Stastny P, Diaz LA (2000) Epitopes targeted by bullous pemphigoid t lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain. J Invest Dermatol 115:955–961

    Article  CAS  PubMed  Google Scholar 

  22. Liu Z, Shapiro SD, Zhou X, Twining SS, Senior RM, Giudice GJ, Fairley JA, Diaz LA (2000) A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest 105:113–123

    CAS  PubMed  Google Scholar 

  23. Liu Z, Zhou X, Shapiro SD, Shipley JM, Twining SS, Diaz LA, Senior RM, Werb Z (2000) The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell 102:647–655

    CAS  PubMed  Google Scholar 

  24. Mascaro JM Jr, Zillikens D, Giudice GJ, Caux F, Fleming MG, Katz HM, Diaz LA (2000) A subepidermal bullous eruption associated with IgG autoantibodies to a 200 kd dermal antigen: the first case report from the United States. J Am Acad Dermatol 42:309–315

    PubMed  Google Scholar 

  25. Roh JY, Yee C, Lazarova Z, Hall RP, Yancey KB (2000) The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis. Br J Dermatol 143:104–111

    Article  CAS  PubMed  Google Scholar 

  26. Schumann H, Baetge J, Tasanen K, Wojnarowska F, Schacke H, Zillikens D, Bruckner-Tuderman L (2000) The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am J Pathol 156:685–695

    CAS  PubMed  Google Scholar 

  27. Stahle-Backdahl M, Inoue M, Guidice GJ, Parks WC (1994) 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J Clin Invest 93:2022–2030

    CAS  PubMed  Google Scholar 

  28. Toto P, Feliciani C, Amerio P, Suzuki H, Wang B, Shivji GM, Woodley D, Sauder DN (2000) Immune modulation in pemphigus vulgaris: role of CD28 and IL-10. J Immunol 164:522–529

    CAS  PubMed  Google Scholar 

  29. Wakugawa M, Nakamura K, Hino H, Toyama K, Hattori N, Okochi H, Yamada H, Hirai K, Tamaki K, Furue M (2000) Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia. Br J Dermatol 143:112–116

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr Mirella Giangiacomi (Institute of Pathology, University of Ancona-Italy) and Edward Browning (Institute of Pathology, The Royal London Hospital, London, UK) for providing H&E and DIF microphotographs.

Author information

Authors and Affiliations

  1. Department of Dermatology, Queen Mary-University of London, The Royal London Hospital, Whitechapel, London, E1 1BB, UK

    Roberto Verdolini & Rino Cerio

Authors
  1. Roberto Verdolini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rino Cerio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberto Verdolini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verdolini, R., Cerio, R. Autoimmune subepidermal bullous skin diseases: the impact of recent findings for the dermatopathologist. Virchows Arch 443, 184–193 (2003). https://doi.org/10.1007/s00428-003-0776-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-003-0776-4

Keywords

Search

Navigation